Research advances in brain-targeted nanoscale drug delivery system.
- Author:
Yang LIU
1
;
Chen JIANG
1
Author Information
1. Key Laboratory of Smart Drug Delivery (Ministry of Education), School of Pharmacy, Fudan University, Shanghai 201203, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Biological Transport;
Blood-Brain Barrier;
Brain;
drug effects;
metabolism;
Central Nervous System Agents;
administration & dosage;
therapeutic use;
Central Nervous System Diseases;
diagnosis;
drug therapy;
Drug Carriers;
Drug Delivery Systems;
methods;
Humans;
Nanoparticles
- From:
Acta Pharmaceutica Sinica
2013;48(10):1532-1543
- CountryChina
- Language:Chinese
-
Abstract:
The blood-brain barrier (BBB) exerts its central nervous system (CNS) protective function as it hinders the delivery of diagnostic and therapeutic agents to the brain. With the development of nanotechnology during the last thirty years, the nanocarriers for delivering drugs make it possible to transport drugs across the BBB. The brain-targeted drug delivery system usually consists of two parts: nanocarriers and brain-targeted strategies. In this review, several kinds of nanocarriers are introduced for brain-targeted drug delivery. We focus on several possible strategies for brain-targeting and comment on their advantages and disadvantages in application.
